Why the study?
Does CMR with T1 mapping improve the detection of underlying structural heart disease and myocardial fibrosis compared to echocardiography in well-controlled hypertensive patients?
Does CMR with T1 mapping improve the detection of underlying structural heart disease and myocardial fibrosis compared to echocardiography in well-controlled hypertensive patients?
CMR with T1 mapping can detect underlying structural heart disease and diffuse myocardial fibrosis missed by echocardiography in well-controlled hypertensive patients.
CMR may detect occult disease missed by echo in controlled hypertension; hypothesis-generating and should not yet change practice.
In well-controlled hypertensive patients, conventional CMR discovered significant underlying diseases (chronic infarction, HCM) not detected by echocardiography previously or even during this study. T1 mapping revealed increased diffuse myocardial fibrosis, but the increases were small and only occurred with LVH.
No takes yet. Share an insight, caveat, or question.
Treibel et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: